Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

ImmunityBio (IBRX) Asset Utilization Ratio (2016 - 2025)

ImmunityBio (IBRX) has disclosed Asset Utilization Ratio for 11 consecutive years, with 0.22 as the latest value for Q4 2025.

  • Quarterly Asset Utilization Ratio rose 462.57% to 0.22 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.22 through Dec 2025, up 462.57% year-over-year, with the annual reading at 0.26 for FY2025, 670.53% up from the prior year.
  • Asset Utilization Ratio for Q4 2025 was 0.22 at ImmunityBio, up from 0.18 in the prior quarter.
  • The five-year high for Asset Utilization Ratio was 0.22 in Q4 2025, with the low at 0.0 in Q1 2024.
  • Average Asset Utilization Ratio over 5 years is 0.04, with a median of 0.0 recorded in 2021.
  • The sharpest move saw Asset Utilization Ratio plummeted 75.45% in 2022, then soared 13527.09% in 2025.
  • Over 5 years, Asset Utilization Ratio stood at 0.0 in 2021, then tumbled by 75.45% to 0.0 in 2022, then skyrocketed by 97.87% to 0.0 in 2023, then soared by 2871.13% to 0.04 in 2024, then soared by 462.57% to 0.22 in 2025.
  • According to Business Quant data, Asset Utilization Ratio over the past three periods came in at 0.22, 0.18, and 0.16 for Q4 2025, Q3 2025, and Q2 2025 respectively.